Top Stories
-
As first-time participants of Velocity, Sam and wife, Terri, pay tribute to the life-changing and innovative care they received.
Topic
-
Congratulations to Lauren Houghton, Chin Hur, Markus D. Siegelin, and Neil Vasan, the new Class of Velocity Fellows, for their innovative, life-changing cancer research.
Topic
-
Researchers from the Herbert Irving Comprehensive Cancer Center presented new research on breast cancer risk prediction at the 2021 San Antonio Breast Cancer Symposium.
Topic
-
On October 3, the Herbert Irving Comprehensive Cancer Center (HICCC) held the fifth annual Velocity, Columbia’s Ride to End Cancer, bringing together supporters of the HICCC.
Latest News
- September 13, 2021
Surviving cancer has driven Dr. Viny's work to uncover better, more effective cancer therapies. He joins Velocity this year to raise funds for critical cancer research and improve care.
Topic
- July 28, 2021
Innovation is at the center of winning research by the new class of Velocity fellows.
-
Source:
CUIMC NewsroomSeptember 28, 2020An annual tradition of the fall season is Velocity: Columbia’s Ride to End Cancer. This year, in response to COVID-19, Velocity is taking a new, personal approach called Your Velocity.
- July 30, 2020
Four Columbia cancer researchers have been selected to share seed funding raised from Velocity, Columbia’s Ride to End Cancer.
Topic
- May 8, 2020
Aaron Garcia, a graduate student at Columbia University’s School of Nursing, is currently working as a nurse technician at NewYork-Presbyterian Hospital on the COVID-19 front lines.
Topic
-
Piero Dalerba, MD is one of the six inaugural Velocity fellows, whose innovative research projects to solve cancer are being funded by the money raised from the Velocity ride.
-
For Dr. Katherine Crew, the annual Velocity ride is an opportunity to join with colleagues, patients,and the community to fight against cancer.
-
Founded by Velocity Riders Sarah Urke and Barbara Trencher, CancerFit’s goal is to provide cancer patients with the benefits of exercise and physical activity.
-
The Phase ONEders represent doctors, researchers, nurses, pharmacists, and clinical research specialists involved in developing the newest immunological and targeted cancer treatments at Columbia.
-
Tour de MORE, a team of faculty, staff, and community partners, including local high-schoolers, are coming together to ride in Velocity, Columbia’s annual fundraiser benefitting cancer research.
